alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › narrative

narrative

8 studies tagged narrative, dated 2022-03-09 to 2026-07-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. A Narrative Review of Amyloid-β Monoclonal Antibodies for Alzheimer Disease: How Amyloid Species Engagement May Affect Clinical Outcomes 2026-07-01
  2. Recent advances in incretin-based therapy for the treatment of cognitive impairment associated to the type 2 diabetes mellitus: preclinical and clinical studies - a narrative review 2025-12-17
  3. Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use 2025-01-14

Studies

8 studies carry this tag.

Date range

2022 to 2026

Top journals

  • Brain communications 2
  • Frontiers in endocrinology 1
  • Frontiers in pharmacology 1
  • International journal of Alzheimer's disease 1
  • JMIR mHealth and uHealth 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A Narrative Review of Amyloid-β Monoclonal Antibodies for Alzheimer Disease: How Amyloid Species Engagement May Affect Clinical Outcomes

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. The neurologist 2026-07-01 Treatments

    Monoclonal antibodies that target Aβ monomers, soluble oligomers and protofibrils, and insoluble fibrils/plaques were developed, and not all have provided clinical benefit.

  2. Recent advances in incretin-based therapy for the treatment of cognitive impairment associated to the type 2 diabetes mellitus: preclinical and clinical studies - a narrative review

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Frontiers in endocrinology 2025-12-17 Drug development

    It is well-established that individuals with type 2 diabetes mellitus (T2DM) have an increased risk of developing cognitive impairment and dementia, suggesting a close relation between hyperglycemia, insulin resistance, and chronic inflammation.

  3. Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. The journal of prevention of Alzheimer's disease 2025-01-14 Biomarkers

    As novel, anti-amyloid therapies have become more widely available, access to timely and accurate diagnosis has become integral to ensuring optimal treatment of patients with early-stage Alzheimer's disease (AD).

  4. Glial fibrillary acidic protein in Alzheimer's disease: a narrative review

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Brain communications 2024-11-07 Biomarkers

    Astrocytes are fundamental in neural functioning and homeostasis in the central nervous system.

  5. Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer's disease: a narrative review

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Frontiers in pharmacology 2024-02-09 Drug development

    Insulin resistance in brain and amyloidogenesis are principal pathological features of diabetes-related cognitive decline and development of Alzheimer's disease (AD).

  6. Online clinical tools to support the use of new plasma biomarker diagnostic technology in the assessment of Alzheimer's disease: a narrative review

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Brain communications 2023-11-24 Biomarkers

    Recent advances in new diagnostic technologies for Alzheimer's disease have improved the speed and precision of diagnosis.

  7. The Feasibility of Using Smartphone Sensors to Track Insomnia, Depression, and Anxiety in Adults and Young Adults: Narrative Review

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. JMIR mHealth and uHealth 2023-02-17 Cognitive tests and assessment

    Extreme sleepiness and insomnia not only influence physical health, they also have a significant impact on mental health, such as by causing depression, which has a prevalence of 18% to 21% among young adults aged 16 to 24 in the United Kingdom.

  8. Aducanumab Therapy to Treat Alzheimer's Disease: A Narrative Review

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. International journal of Alzheimer's disease 2022-03-09 Treatments

    Despite the limitations, aducanumab is the first disease-modifying therapy approved for the treatment of AD.

All topic tags with their study counts